177Lu-PSMA-I&T Demonstrates PSA Responses and a Manageable Toxicity Profile
Radioligand therapy with 177Lu-PSMA-I&T elicited favorable PSA responses and a safety profile similar to PSMA-617.
Source: oncnursingnews.com
Stay updated with breaking news from Psa Responses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Radioligand therapy with 177Lu-PSMA-I&T elicited favorable PSA responses and a safety profile similar to PSMA-617.